Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Tracon Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q1 2022
- Shares held
- 9.87M
- +740.3K (+8.1%) vs. Q1 2022
- Total value
- $19.7M
- −$4.27M (−17.8%) vs. Q1 2022
- New holders
- 2
- 7 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 24 | $903.4K |
| Q3 2023 | 21 | $1.66M |
| Q2 2023 | 27 | $2.90M |
| Q1 2023 | 32 | $18.8M |
| Q4 2022 | 32 | $14.6M |
| Q3 2022 | 33 | $16.5M |
| Q2 2022 | 31 | $19.7M |
| Q1 2022 | 35 | $24.0M |
| Q4 2021 | 35 | $25.4M |
| Q3 2021 | 45 | $39.6M |
| Q2 2021 | 44 | $58.5M |
| Q1 2021 | 42 | $72.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8.25M | 3.72% | +970,224+30.8% | Added |
| Ikarian Capital, LLC | 2,788,853 | $5.58M | 2.31% | −54,379−1.9% | Reduced |
| Vanguard Group Inc | 590,688 | $1.18M | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 454,916 | $910.0K | 0.01% | 00.0% | Unchanged |
| NEA Management Company, LLC | 346,719 | $693.0K | 0.04% | 00.0% | Unchanged |
| BlackRock Inc. | 305,410 | $611.0K | 0.00% | +5,789+1.9% | Added |
| Boothbay Fund Management, LLC | 268,301 | $537.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 160,500 | $321.0K | 0.00% | −48,500−23.2% | Reduced |
| Geode Capital Management, LLC | 156,158 | $312.0K | 0.00% | +3,098+2.0% | Added |
| Telemetry Investments, L.L.C. | 100,000 | $200.0K | 0.30% | +33,000+49.3% | Added |
| Johnson & Johnson | 84,003 | $168.0K | 0.04% | 00.0% | Unchanged |
| State Street Corp | 75,154 | $150.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 75,228 | $150.0K | 0.00% | +75,228 | New |
| Bank of New York Mellon Corp | 67,046 | $134.0K | 0.00% | −75,207−52.9% | Reduced |
| Renaissance Technologies LLC | 52,600 | $105.0K | 0.00% | +23,400+80.1% | Added |
| Dowling & Yahnke LLC | 47,455 | $95.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 41,279 | $83.0K | 0.00% | −41,221−50.0% | Reduced |
| ACT Capital Management, LLC | 28,500 | $57.0K | 0.08% | 00.0% | Unchanged |
| CSS LLC | 25,119 | $50.0K | 0.00% | −3,000−10.7% | Reduced |
| X-Square Capital, LLC | 17,973 | $36.0K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 17,337 | $35.0K | 0.00% | 00.0% | Unchanged |
| Hoylecohen, LLC | 13,000 | $26.0K | 0.00% | 00.0% | Unchanged |
| We Are One Seven, LLC | 11,780 | $24.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,050 | $20.0K | 0.00% | −353−3.4% | Reduced |
| Group One Trading, L.P. | 3,600 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,620 | $3.00K | 0.00% | +1,358+518.3% | Added |
| Cutler Group LP | 1,200 | $2.00K | 0.00% | −15,000−92.6% | Reduced |
| Wells Fargo & Company | 910 | $2.00K | 0.00% | +14+1.6% | Added |
| TCI Wealth Advisors, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 318 | $1.00K | 0.00% | +318 | New |
| Simplex Trading, LLC | 256 | $0 | 0.00% | −10,714−97.7% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −49,743−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −43,700−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −19,563−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,828−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,940−100.0% | Sold out |